Dyslipidemia and aortic valve disease.

Mata, Pedro; Alonso, Rodrigo; Pérez de Isla, Leopoldo; Badimón, Lina

Mata, Pedro; Alonso, Rodrigo; Pérez de Isla, Leopoldo; Badimón, Lina.

Affiliation

Mata P; Fundación Hipercolesterolemia Familiar, Madrid, Spain.
Alonso R; Fundación Hipercolesterolemia Familiar, Madrid, Spain.
Pérez de Isla L; Center for Advanced Metabolic Medicine and Nutrition, Santiago, Chile.
Badimón L; Fundación Hipercolesterolemia Familiar, Madrid, Spain.

Curr Opin Lipidol ; 32(6): 349-354, 2021 12 01.

Article in En | MEDLINE | ID: mdl-34629429

Subject(s)

Aortic Valve Stenosis; Dyslipidemias; Hypercholesterolemia; Adult; Aortic Valve Stenosis/epidemiology; Aortic Valve Stenosis/genetics; Cholesterol, LDL; Dyslipidemias/complications; Dyslipidemias/genetics; Humans; Hypercholesterolemia/drug therapy; Lipoprotein(a); Proprotein Convertase 9/genetics; Proprotein Convertase 9/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aortic Valve Stenosis / Dyslipidemias / Hypercholesterolemia Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Humans Language: En Journal: Curr Opin Lipidol Journal subject: BIOQUIMICA Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google